Literature DB >> 34220005

Genetic Association of rs2237572 Cyclin-Dependent Kinase 6 Gene with Breast Cancer in Iraq.

Dalya Sh Al-Owaidi1, Moaed E Algazally1,2, Alaa Sadeq Alawaad3.   

Abstract

This case-control study is aimed to evaluate serum concentration of Cyclin-Dependent Kinase 6 (CDK6) and the genetic association between rs2237572 CDK6 gene and breast cancer (BC) in Iraq. To attain this goal, 80 patients with BC as cases and 80 healthy individuals as controls were included. Further, BC patients were sorted according to the molecular classification into four subtypes of Luminal A, Luminal B, Her2/neu enriched and TPN. Serum concentration of CDK6 enzyme, allelic and genotypic frequencies of rs2237572 CDK6, and the occurrence of BC phenotype and its subtypes in the studied population were investigated. ELISA technique was used to perform the biochemical testing, while the molecular analysis was achieved by real-time PCR, high resolution melting analysis, conventional PCR, as well as sequencing analysis. The results revealed no significant difference in serum concentration of CDK6 enzyme between patients and healthy controls (p > 0.05). Also, no significant differences were shown between BC patients subtypes (p > 0.05). The rs2237572 CDK6 genotypes were associated with the BC and affirmed that allele C was inherited as a recessive risk factor. Moreover, a highly significant difference between patients' subtypes in the genotypic frequency of rs2237572 (p < 0.01) was noted. Furthermore, the association of rs2237572 genotypes and CDK6 serum concentration in BC patients showed a considered significant difference between C/C and T/T, C/C and T/C and the CDK6 level (p < 0.05). Nevertheless, T/T and T/C did not show any significant difference with the CDK6 level. Hence, it was concluded that the rs2237572 of CDK6 gene is significantly correlated with BC. © Association of Clinical Biochemists of India 2020.

Entities:  

Keywords:  Breast cancer; Cell cycle; Cyclin D; Cyclin-dependent kinase 6; rs2237572

Year:  2020        PMID: 34220005      PMCID: PMC8215008          DOI: 10.1007/s12291-020-00895-5

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  22 in total

Review 1.  The Role of CDK4/6 Inhibition in Breast Cancer.

Authors:  Conleth G Murphy; Maura N Dickler
Journal:  Oncologist       Date:  2015-04-15

2.  Urinary estrogen metabolites and mammographic parenchymal patterns in postmenopausal women.

Authors:  E Riza; I dos Santos Silva; B De Stavola; H L Bradlow; D W Sepkovic; D Linos; A Linos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-06       Impact factor: 4.254

3.  Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.

Authors:  A J Whelan; D Bartsch; P J Goodfellow
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

4.  Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.

Authors:  Frank Mendrzyk; Bernhard Radlwimmer; Stefan Joos; Felix Kokocinski; Axel Benner; Daniel E Stange; Kai Neben; Heike Fiegler; Nigel P Carter; Guido Reifenberger; Andrey Korshunov; Peter Lichter
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

Review 5.  Breast cancer genomes--form and function.

Authors:  James Korkola; Joe W Gray
Journal:  Curr Opin Genet Dev       Date:  2010-01-07       Impact factor: 5.578

Review 6.  Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.

Authors:  Chantal Guillemette; Alain Bélanger; Johanie Lépine
Journal:  Breast Cancer Res       Date:  2004-09-27       Impact factor: 6.466

Review 7.  Ethnic background and genetic variation in the evaluation of cancer risk: a systematic review.

Authors:  Lijun Jing; Li Su; Brian Z Ring
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

8.  CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation.

Authors:  Alessandra Dall'Acqua; Maura Sonego; Ilenia Pellizzari; Ilenia Pellarin; Vincenzo Canzonieri; Sara D'Andrea; Sara Benevol; Roberto Sorio; Giorgio Giorda; Daniela Califano; Marina Bagnoli; Loredana Militello; Delia Mezzanzanica; Gennaro Chiappetta; Joshua Armenia; Barbara Belletti; Monica Schiappacassi; Gustavo Baldassarre
Journal:  EMBO Mol Med       Date:  2017-10       Impact factor: 12.137

9.  Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.

Authors:  Kristy E Driver; Honglin Song; Fabienne Lesueur; Shahana Ahmed; Nuno L Barbosa-Morais; Jonathan P Tyrer; Bruce A J Ponder; Douglas F Easton; Paul D P Pharoah; Alison M Dunning
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

10.  Ensemble inference by integrative cancer networks.

Authors:  Antonio Mora; Monia Taranta; Nazar Zaki; Elarbi Badidi; Caterina Cinti; Enrico Capobianco
Journal:  Front Genet       Date:  2014-03-31       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.